These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 15733464

  • 1. [The influence of neuroendocrine differentiation on the growth and androgen receptor expression of prostate carcinoma cells].
    Song Y, Wu G, Xin DQ, Na YQ.
    Zhonghua Wai Ke Za Zhi; 2004 Dec 07; 42(23):1453-6. PubMed ID: 15733464
    [Abstract] [Full Text] [Related]

  • 2. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
    Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ.
    Cancer Res; 2004 Aug 01; 64(15):5489-95. PubMed ID: 15289359
    [Abstract] [Full Text] [Related]

  • 3. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
    Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM, Ouafik L.
    Oncogene; 2008 Jan 17; 27(4):506-18. PubMed ID: 17637748
    [Abstract] [Full Text] [Related]

  • 4. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
    Jongsma J, Oomen MH, Noordzij MA, Van Weerden WM, Martens GJ, van der Kwast TH, Schröder FH, van Steenbrugge GJ.
    Cancer Res; 2000 Feb 01; 60(3):741-8. PubMed ID: 10676662
    [Abstract] [Full Text] [Related]

  • 5. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF.
    Endocr Relat Cancer; 2006 Mar 01; 13(1):151-67. PubMed ID: 16601285
    [Abstract] [Full Text] [Related]

  • 6. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cox ME, Deeble PD, Lakhani S, Parsons SJ.
    Cancer Res; 1999 Aug 01; 59(15):3821-30. PubMed ID: 10447001
    [Abstract] [Full Text] [Related]

  • 7. Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cancer.
    Wu C, Zhang L, Bourne PA, Reeder JE, di Sant'Agnese PA, Yao JL, Na Y, Huang J.
    Prostate; 2006 Aug 01; 66(11):1125-35. PubMed ID: 16652382
    [Abstract] [Full Text] [Related]

  • 8. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.
    Uchida K, Masumori N, Takahashi A, Itoh N, Kato K, Matusik RJ, Tsukamoto T.
    Prostate; 2006 Apr 01; 66(5):536-45. PubMed ID: 16372327
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC.
    Prostate; 2007 May 15; 67(7):764-73. PubMed ID: 17373716
    [Abstract] [Full Text] [Related]

  • 10. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW, Lau KW, Tam PC, Shiu SY.
    Prostate; 2002 Jul 01; 52(2):106-22. PubMed ID: 12111702
    [Abstract] [Full Text] [Related]

  • 11. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.
    Zhang Z, Zhao Y, Batres Y, Lin MF, Ying SY.
    Biochem Biophys Res Commun; 1997 May 19; 234(2):362-5. PubMed ID: 9177276
    [Abstract] [Full Text] [Related]

  • 12. Androgen dependent regulation of protein kinase A subunits in prostate cancer cells.
    Kvissel AK, Ramberg H, Eide T, Svindland A, Skålhegg BS, Taskén KA.
    Cell Signal; 2007 Feb 19; 19(2):401-9. PubMed ID: 16949795
    [Abstract] [Full Text] [Related]

  • 13. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
    Alberti C.
    G Chir; 2010 Feb 19; 31(11-12):568-74. PubMed ID: 21232206
    [Abstract] [Full Text] [Related]

  • 14. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 15. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells.
    Xie S, Lin HK, Ni J, Yang L, Wang L, di Sant'Agnese PA, Chang C.
    Prostate; 2004 Jun 15; 60(1):61-7. PubMed ID: 15129430
    [Abstract] [Full Text] [Related]

  • 16. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM, Ouafik L.
    Cancer Res; 2001 Feb 01; 61(3):1196-206. PubMed ID: 11221851
    [Abstract] [Full Text] [Related]

  • 17. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
    Valentini A, Biancolella M, Amati F, Gravina P, Miano R, Chillemi G, Farcomeni A, Bueno S, Vespasiani G, Desideri A, Federici G, Novelli G, Bernardini S.
    Drug Metab Dispos; 2007 Jun 01; 35(6):968-72. PubMed ID: 17371798
    [Abstract] [Full Text] [Related]

  • 18. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
    Jennbacken K, Tesan T, Wang W, Gustavsson H, Damber JE, Welén K.
    Endocr Relat Cancer; 2010 Jun 01; 17(2):469-79. PubMed ID: 20233707
    [Abstract] [Full Text] [Related]

  • 19. Cryoablative response of prostate cancer cells is influenced by androgen receptor expression.
    Klossner DP, Baust JM, VanBuskirk RG, Gage AA, Baust JG.
    BJU Int; 2008 May 01; 101(10):1310-6. PubMed ID: 18261151
    [Abstract] [Full Text] [Related]

  • 20. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
    Lee SO, Dutt SS, Nadiminty N, Pinder E, Liao H, Gao AC.
    Prostate; 2007 Sep 01; 67(12):1293-300. PubMed ID: 17626246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.